HIMS
Hims Hers Health Inc
29.50$
+0.2%
vs. previous close
Closing price · As of: Oct 7, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +8.8% | +12.8% | +13.5% | +27.2% | +19.8% | +21.8% | -7.0% | +9.9% | +3.1% | -1.6% | +23.9% | – | |
| – | +8.0% | +15.3% | +20.3% | +41.7% | +33.4% | +39.2% | -17.2% | +22.0% | +10.5% | +77.5% | -11.5% | – | |
| – | +8.9% | +12.3% | +12.0% | +23.9% | +16.2% | +16.5% | -3.4% | +6.2% | +0.5% | -32.4% | +60.1% | – | |
| – | +9.3% | +14.3% | +21.7% | +13.1% | +12.6% | +26.0% | +26.5% | +7.2% | +0.9% | +14.6% | +17.0% | – | |
| – | -10.0% | +7.0% | +17.3% | +10.0% | +7.6% | +1.2% | +38.4% | +19.9% | -5.6% | +44.0% | +50.8% | – | |
| – | +4.4% | +7.2% | +12.0% | +20.3% | +18.8% | +6.2% | +4.5% | +10.5% | +1.2% | -27.2% | +82.5% | – | |
| – | – | – | +11.4% | +102.8% | -16.9% | +211.3% | -53.8% | -55.8% | -22.2% | -279.3% | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | +464.8% | +8.2% | +75.8% | -5.5% | +171.4% | -45.7% | -62.8% | +50.2% | -653.3% | – | – | |
| – | +46.1% | +34.1% | -90.0% | -41,040.9% | – | – | -187.7% | – | – | – | – | – | |
| – | – | +793.8% | +19.5% | +468.5% | -65.6% | +90.1% | -14.1% | -62.9% | +30.6% | -547.1% | – | – | |
| – | – | +217.3% | +10.8% | +63.9% | +1.3% | +142.6% | -37.0% | -31.0% | +21.9% | -318.4% | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 7, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.